A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery
- PMID: 30849470
- PMCID: PMC6562166
- DOI: 10.1016/j.ijpharm.2019.03.004
A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery
Abstract
The present study evaluates the effect of L-leucine concentration and operating parameters of a laboratory spray dryer on characteristics of trehalose dry powders, with the goal of optimizing production of these powders for inhaled drug delivery. Trehalose/L-leucine mixtures were spray dried from aqueous solution using a laboratory spray dryer. A factorial design of experiment (DoE) was undertaken and process parameters adjusted were: inlet temperature, gas flow rate, feed solution flow rate (pump setting), aspiration setting and L-leucine concentration. Resulting powders were characterised in terms of particle size, yield, residual moisture content, and glass transition temperature. Particle size was mainly influenced by gas flow rate, whereas product yield and residual moisture content were found to be primarily affected by inlet temperature and spray solution feed rate respectively. Interactions between a number of different process parameters were elucidated, as were relationships between different responses. The leucine mass ratio influenced the physical stability of powders against environmental humidity, and a high leucine concentration (30% w/w) protected amorphous trehalose from moisture induced crystallization. High weight ratio of leucine in the formulation, however, negatively impacted the aerosol performance. Thus, in terms of L-leucine inclusion in a formulation designed for pulmonary delivery, a balance needs to be found between physical stability and deposition characteristics.
Keywords: DPI; Design of experiments; Dry powder for inhalation; Leucine; Pulmonary formulation; Spray drying; Trehalose.
Copyright © 2019 Elsevier B.V. All rights reserved.
Figures
References
-
- Amaro MI, Tajber L, Corrigan OI, Healy AM, 2011. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation. International Journal of Pharmaceutics 421, 99–109. - PubMed
-
- Amaro MI, Tajber L, Corrigan OI, Healy AM, 2015a. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-beta-cyclodextrin with amorphous raffinose or trehalose. Pharm Res 32, 180–195. - PubMed
-
- Amaro MI, Tewes F, Gobbo O, Tajber L, Corrigan OI, Ehrhardt C, Healy AM, 2015b. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation. International Journal of Pharmaceutics 483, 6–18. - PubMed
-
- Aquino RP, Prota L, Auriemma G, Santoro A, Mencherini T, Colombo G, Russo P, 2012. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells. International Journal of Pharmaceutics 426, 100–107. - PubMed
-
- Billon A, Bataille B, Cassanas G, Jacob M, 2000. Development of spray-dried acetaminophen microparticles using experimental designs. International Journal of Pharmaceutics 203, 159–168. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
